115 related articles for article (PubMed ID: 38039046)
1. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
[TBL] [Abstract][Full Text] [Related]
2. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
Bian F; Li C; Han D; Xu F; Lyu J
Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
[TBL] [Abstract][Full Text] [Related]
3. A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
Yu Z; Yang J; Gao L; Huang Q; Zi H; Li X
Med Sci Monit; 2020 Jan; 26():e918686. PubMed ID: 31966000
[TBL] [Abstract][Full Text] [Related]
4. Competing-risks analysis for evaluating the prognosis of patients with microinvasive cutaneous squamous cell carcinoma based on the SEER database.
Zheng S; Xie S; Yu H; Duan X; He Y; Ho C; Wan Y; Hang T; Chen W; Lyu J; Deng L
BMC Med Res Methodol; 2023 Dec; 23(1):286. PubMed ID: 38062392
[TBL] [Abstract][Full Text] [Related]
5. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
[TBL] [Abstract][Full Text] [Related]
6. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H; Jiang S; Zhong P; Li W; Zhang S
J Ovarian Res; 2021 Oct; 14(1):137. PubMed ID: 34674727
[TBL] [Abstract][Full Text] [Related]
7. Competitive Risk Analysis of Prognosis in Patients With Cecum Cancer: A Population-Based Study.
Wu W; Yang J; Li D; Huang Q; Zhao F; Feng X; Yan H; Lyu J
Cancer Control; 2021; 28():1073274821989316. PubMed ID: 33491489
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.
Zhang X; Yang J; Huang Q; Lyu J
Scand J Gastroenterol; 2019 Aug; 54(8):1015-1021. PubMed ID: 31382800
[No Abstract] [Full Text] [Related]
9. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for squamous cervical carcinoma identified by competing-risks analysis: A study based on the SEER database.
Hu C; Cao J; Zeng L; Luo Y; Fan H
Medicine (Baltimore); 2022 Sep; 101(39):e30901. PubMed ID: 36181049
[TBL] [Abstract][Full Text] [Related]
12. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
13. Competing-risks model for predicting the prognosis of penile cancer based on the SEER database.
Yang J; Pan Z; He Y; Zhao F; Feng X; Liu Q; Lyu J
Cancer Med; 2019 Dec; 8(18):7881-7889. PubMed ID: 31657120
[TBL] [Abstract][Full Text] [Related]
14. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
15. Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database.
Li X; Yang Q; Chen M; Yang C; Gu J; Dong Q; Yang G
J Ovarian Res; 2021 Feb; 14(1):40. PubMed ID: 33640000
[TBL] [Abstract][Full Text] [Related]
16. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
17. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database.
Han D; Yang J; Xu F; Huang Q; Bai L; Wei YL; Kaaya RE; Wang S; Lyu J
Medicine (Baltimore); 2020 Jul; 99(31):e21322. PubMed ID: 32756116
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
Li S; Zhu Z
J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
[TBL] [Abstract][Full Text] [Related]
20. The Prevalence, Associated Factors for Lung Metastases Development and Prognosis in Ovarian Serous Cancer Based on SEER Database.
Cao C; Yang X
Technol Cancer Res Treat; 2020; 19():1533033820983801. PubMed ID: 33356997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]